Zum Hauptinhalt springen

Bypass

Zuletzt bearbeitet: Zuletzt revidiert:
Zuletzt revidiert von:
  • Deutsche Gesellschaft für Allgemeinmedizin (DEGAM). Neue Thrombozyten-Aggregationshemmer, Einsatz in der Hausarztpraxis. DEGAM-Leitlinie Nr. 16, AWMF-Leitlinie Nr. 053-041. S2e, Stand 2019. www.awmf.org 
  • European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. Guidelines on myocardial revascularization, Stand 2014. www.escardio.org 
  • Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische KHK, 5. Auflage. AWMF-Nr. nvl-004. S3, Stand 2019. www.awmf.org 
  1. Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie. Herzchirurgische Eingriffe, letzter Zugriff 21.3.17. www.dgthg.de  
  2. European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. Guidelines on myocardial revascularization, Stand 2014. academic.oup.com  
  3. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische KHK, Stand 2015. www.awmf.org  
  4. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996; 28: 616 - 26. PubMed  
  5. Campeau L, Enjalbert M, Lesperance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 1983; 68: II1-7. www.ncbi.nlm.nih.gov  
  6. Shahian DM, O'Brien SM, Sheng S, et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation 2012; 125:1491. www.ncbi.nlm.nih.gov  
  7. Wu C, Camacho FT, Wechsler AS, et al. Risk score for predicting long-term mortality after coronary artery bypass graft surgery. Circulation 2012; 125:2423. www.ncbi.nlm.nih.gov  
  8. Gorenoi V, Schonermark MP, Hagen A. Perkutane Koronarinterventionen zusätzlich zur optimalen medikamentösen Therapie bei stabiler Angina Pectoris. GMS Health Technol Assess 2011;7:Doc07. www.egms.de  
  9. Thomas S, Gokhale R, Boden WE, et al. A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris. Can J Cardiol 2013;29(4):472-82. www.ncbi.nlm.nih.gov  
  10. Stergiopoulos K, Boden WE, Hartigan P, et al. Percutaneous Coronary Intervention Outcomes in Patients With Stable Obstructive Coronary Artery Disease and Myocardial Ischemia: A Collaborative Meta-analysis of Contemporary Randomized Clinical Trials. JAMA Intern Med 2014;174(2):232-40. www.ncbi.nlm.nih.gov  
  11. Pursnani S, Korley F, Gopaul R, et al. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv 2012;5(4):476-90. www.ncbi.nlm.nih.gov  
  12. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med 2012;172(4):312-9. www.ncbi.nlm.nih.gov  
  13. Jeremias A, Kaul S, Rosengart TK, et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 2009;122(2):152-61. www.ncbi.nlm.nih.gov  
  14. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344(8922):563-70. www.ncbi.nlm.nih.gov  
  15. Kapoor JR, Gienger AL, Ardehali R, et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. JACC Cardiovasc Interv 2008;1(5):483-91. www.ncbi.nlm.nih.gov  
  16. Aziz O, Rao C, Panesar SS, et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007;334(7594):617. www.ncbi.nlm.nih.gov  
  17. Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. Journal of the American College of Cardiology 2010;55(5):432-40. www.ncbi.nlm.nih.gov  
  18. Li X, Kong M, Jiang D, et al. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis. Interact Cardiovasc Thorac Surg 2014;18(3):347-54 www.ncbi.nlm.nih.gov  
  19. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563 - 70. PubMed  
  20. Veldkamp RF, Valk SD, van Domburg RT, van Herwerden LA, Meeter K. Mortality and repeat interventions up until 20 years after aorto-coronary bypass surgery with saphenous vein grafts. A follow-up study of 1041 patients. Eur Heart J 2000; 21:747-53. www.ncbi.nlm.nih.gov  
  21. Cameron A, Kemp HG, Green GE. Bypass surgery with the internal mammary artery graft: 15 year followup. Circulation 1986; 74 (suppl 3): 30-6. www.ncbi.nlm.nih.gov  
  22. Wilson YG. Vein quality in infrainguinal revascularisation: assessment by angioscopy and histology. Ann R Coll Surg Engl 1998; 80: 3 - 15. PubMed  
  23. Steen S. Preservation of the endothelium in cardiovascular surgery - some practical suggestions - a review. Scand Cardiovasc J 2001; 35: 297 - 301. PubMed  
  24. Bourassa MG, Campeau L, Lesperance J. Changes in grafts and coronary arteries after coronary bypass surgery. Cardiovasc Clin 1991; 21: 83 - 100. PubMed  
  25. Maniar HS, Sundt TM, Barner HB, Prasad SM, Peterson L, Absi T et al. Effect of target stenosis and location on radial artery graft patency. J Thorac Cardiovasc Surg 2002; 123: 45 - 52. PubMed  
  26. Endo M, Nishida H, Tomizawa Y, Kasanuki H. Benefit of bilateral over single internal mammay artery grafts for multiple coronary artery bypass grafting. Circulation 2001; 104: 2164-70. www.ncbi.nlm.nih.gov  
  27. Lytle BW, Loop FD. Superiority of bilateral internal thoracic artery grafting. It's been a long time comin'. Circulation 2001; 104: 2152-4. www.ncbi.nlm.nih.gov  
  28. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Coormastic M, Williams GW, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314: 1 - 6. PubMed  
  29. Deutsche Gesellschaft für Allgemeinmedizin (DEGAM). Neue Thrombozyten-Aggregationshemmer, Einsatz in der Hausarztpraxis. DEGAM-Leitlinie Nr. 16, AWMF-Leitlinie Nr. 053-041. Stand 2019. www.awmf.org  
  • Günther Egidi, Dr. med., Facharzt für Allgemeinmedizin, Bremen (Review)
  • Dirk Nonhoff, Dr. med., Facharzt für Allgemeinmedizin, Köln
  • Eva Swahn, professor och överläkare, Kardiologiska kliniken, Universitetssjukhuset Linköping